Cannell & Spears’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,000
Closed -$34.2K 447
2026
Q1
$34.2K Hold
10,000
﹤0.01% 419
2025
Q4
$28.3K Hold
10,000
﹤0.01% 411
2025
Q3
$69.6K Hold
10,000
﹤0.01% 399
2025
Q2
$59.2K Sell
10,000
-52,505
-84% -$302K ﹤0.01% 389
2025
Q1
$399K Sell
62,505
-425
-0.7% -$4.1K 0.01% 300
2024
Q4
$748K Buy
62,930
+52,930
+529% +$902K 0.02% 259
2024
Q3
$277K Buy
+10,000
New +$250K 0.01% 348

Other funds holding ASPN

Cannell & Spears's ASPN Position: Q2 2026 in Review

Cannell & Spears sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 10,000 shares — an estimated $34.2K sold.

Cannell & Spears first reported a position in ASPN in Q3 2024 and held it in 7 quarters. The position peaked at $748K in Q4 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Cannell & Spears reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • Cannell & Spears sold 10,000 Aspen Aerogels shares in Q2 2026, an estimated $34.2K.
  • Cannell & Spears first reported a position in Aspen Aerogels in Q3 2024 and held it in 7 quarters.
  • Cannell & Spears's Aspen Aerogels position peaked at $748K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.